In a post published on November 11, 2026, Google DeepMind states that AlphaGenome 2 is available today for non-commercial research via the AlphaGenome API, and in private preview for commercial research.
✓ DELIVERED · settled 2026-11-15
| Claim made in | AlphaGenome 2: Deciphering how cells read DNA to better understand disease (deepmind.google) |
| Bank record | Google DeepMind — see its full delivery record in the bank |
| Market opened | 2026-11-12 |
| Market type | Flash market (1–3 days) |
| Calls lock | 2026-11-13 07:00 Eastern Time (12:00 UTC) — 24 hours before the check, so nobody can call it with the answer already visible |
| Check time | 2026-11-14 07:00 Eastern Time (12:00 UTC) |
| Source of record | deepmind.google |
Background
DeepMind's next DNA model stops averaging across whole tissues and predicts variant effects inside specific cell types and states. Trained on more than 100 million individual cell profiles across 68 tissues, AlphaGenome 2 is a conditional model: feed it a tissue or cell type alongside the DNA sequence and it predicts how that stretch is read there. On the TenK10K map of 28 immune cell types it found nearly twice as many causal variants as the original model (30% vs 16%) and called the direction of gene effects far more often (43% vs 23%), and it reproduced a known IBD finding computationally, singling out the variant that overactivates ETS2 in gut macrophages. It is available today for non-commercial research through the AlphaGenome API, with commercial research in private preview, for research use only.
This market exists because launch announcements are easy to make and hard to grade. Press releases describe what a company intends to ship; they rarely come back later to say whether it shipped. AI Rank Bank pulls one checkable sentence out of the coverage — the sentence above — gives it a date, and lets readers price it in public. The launch itself stays with its publisher; what lives here is the claim, the crowd's call, and eventually the receipt.
How this claim is judged
Judging criteria, fixed when the market opened: Delivered if, at the check time, Google DeepMind's post remains published stating that AlphaGenome 2 is available today for non-commercial research via the AlphaGenome API and in private preview for commercial research.
The source of record is the publisher's own page linked above. A claim about a company's product is judged against that company's public output — its product pages, documentation, changelogs and official posts — not against rumors or third-party summaries. Only yes-or-no outcomes count: partial credit is not a verdict, and a claim that needs a paragraph of excuses has already answered itself.
How readers called it
1 reader called this claim. 100% said it would deliver.
1 Will deliver · 0 Won't ship · final split when the market locked
Points reward being right against the crowd. A correct call pays 100 × (1 − the share of readers who agreed with you when you placed it), with a floor of 10: side with a 90% consensus and a win pays 10, stand alone and a win pays up to 100. Wrong calls pay nothing. The price is locked in when the call is placed, so early readers are paid for judging before the crowd forms, not for copying it.
How readers split
Share of readers saying “will deliver”: opened at 0%, now at 100%. 27 snapshots on record since 2026-11-13 — a snapshot lands whenever a call is placed, and at least hourly while the market is open.
Verdict
✓ DELIVERED — checked against the source of record and settled on 2026-11-15. The evidence is public: https://deepmind.google/blog/alphagenome-2-deciphering-how-cells-read-dna-to-better-understand-disease/. Readers placed 1 call on this claim; 100% of them said it would deliver. The market paid out 50 points in total. Verdicts are permanent. If the evidence ever shows this stamp was wrong, the record is corrected openly and the correction stays on this page.
About this market
AI Rank Bank is an AI news front page with a memory. Every launch on the homepage carries one claim like this one, with a check date. Readers call claims with points, build a public record, and climb the leaderboard. Companies build a record too: every settled claim lands on the company's bank page, where its delivery rate is simple arithmetic that nobody gets to edit afterwards. There is no money in the market — points buy bragging rights only, which keeps the incentives pointed at being right.